Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)
Close on Nov 18, 2026Market cap $30.81MP/E –Yield –
Alterity Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2026 it was -A$22.52M. The highest annual figure on record is -A$5.87M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -A$22.52M | – |
| FY2025 | Jun 30, 2025 | -A$11.45M | – |
| FY2024 | Jun 30, 2024 | -A$12.61M | – |
| FY2023 | Jun 30, 2023 | -A$20.04M | – |
| FY2022 | Jun 30, 2022 | -A$12.34M | – |
| FY2021 | Jun 30, 2021 | -A$17.33M | – |
| FY2020 | Jun 30, 2020 | -A$9.43M | – |
| FY2019 | Jun 30, 2019 | -A$13.95M | – |
| FY2018 | Jun 30, 2018 | -A$6.25M | – |
| FY2017 | Jun 30, 2017 | -A$5.87M | – |
| FY2016 | Jun 30, 2016 | -A$7.42M | – |
See a number that looks wrong?